Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Article in English, Spanish | MEDLINE | ID: mdl-29661653

ABSTRACT

Bone metastatic disease is the main cause of morbidity / mortality in patients with prostate cancer, presenting frequently as bone pain, pathological fractures or spinal cord compression, which requires early and timely therapy. Although, for the moment, the therapeutic window for its use has not been definitively established, radium-223 (223Ra), an alpha particle emitter, has proved to be an effective therapeutic tool, pre or post-chemotherapy, in patients with castration-resistant prostate cancer with symptomatic bone metastases and absence of visceral metastases, significantly modifying the prognosis of the disease. It is therefore imperative to define the ideal scenarios and the correct protocol for the use of this therapy and thus offer the greatest possible clinical benefit to the patient.


Subject(s)
Bone Neoplasms/radiotherapy , Prostatic Neoplasms, Castration-Resistant/pathology , Radium/therapeutic use , Bone Neoplasms/secondary , Humans , Male , Radiotherapy Dosage
2.
Actas Urol Esp ; 38(7): 429-37, 2014 Sep.
Article in English, Spanish | MEDLINE | ID: mdl-24836925

ABSTRACT

OBJECTIVE: Mediterranean diet may play a role in the prevention of prostate cancer (PCa) development and progression. Cyclooxygenase-2 (COX-2) expression is associated with increased cellular proliferation, prevents apoptosis and favors tumor invasion. We intend to clarify whether resveratrol and other polyphenols effectively inhibit COX-2 activity and induce apoptosis in hormone-resistant PC-3 cell line. MATERIAL AND METHOD: PC-3 cells were cultured and treated with different concentrations of gallic acid, tannic acid, quercetin, and resveratrol in presence of phorbol myristate acetate (PMA; 50 µg/ml) that induces COX-2 expression. Total RNA was extracted and COX-2 expression was analyzed by relative quantification real-time PCR (ΔΔCt method). COX-2 activity was determined by PGE-2 detection using ELISA. Caspase 3/7 luminescence assay was used to disclose apoptosis. Transitory transfection with short human COX-2 (phPES2 -327/+59) and p5xNF-kß-Luc plasmids determined COX-2 promoter activity and specifically that dependant of NF-kß. RESULTS: COX-2 expression was not modified in media devoid of PMA. However, under PMA induction tannic acid (2.08 ±.21), gallic acid (2.46 ±.16), quercetin (1.78 ±.14) and resveratrol (1.15 ±.16) significantly inhibited COX-2 mRNA with respect to control (3.14 ±.07), what means a 34%, 23%, 46% and 61% reduction, respectively. The inhibition in the levels of PGE-2 followed a similar pattern. All compounds studied induced apoptosis at 48 h, although at a different rate. PMA caused a rise in activity 7.4 ±.23 times phPES2 -327/+59 and 2.0 ±.1 times p5xNF-kß-Luc at 6h compared to basal. Resveratrol suppressed these effects 17.1 ±.21 and 32.4 ±.18 times, respectively. Similarly, but to a lesser extent, the rest of evaluated polyphenols diminished PMA inductor effect on the activity of both promoters. CONCLUSIONS: Polyphenols inhibit transcriptional activity of COX-2 promoter mediated by NF-kß. This effect could explain, at least in part, the induction of apoptosis in vitro by these substances in castration resistant PCa.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2/genetics , NF-kappa B/physiology , Polyphenols/pharmacology , Promoter Regions, Genetic/drug effects , Prostatic Neoplasms, Castration-Resistant/pathology , Stilbenes/pharmacology , Transcriptional Activation/drug effects , Wine , Cell Line, Tumor/drug effects , Cyclooxygenase 2/physiology , Drug Screening Assays, Antitumor , Humans , Male , Resveratrol
SELECTION OF CITATIONS
SEARCH DETAIL